Patrick Souverein

Utrecht University

Netherlands

Research Interests

Explore related searches

Professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (11)

Harsha D. Devalla

Amsterdam University Medical Centers

NETHERLANDS

View details

Sander van Doorn

University Medical Center Groningen

NETHERLANDS

View details

Tessel Rigter

University of Amsterdam

NETHERLANDS

View details

Martina Cornel

Professor of Community Genetics and Public Health Genomics

Amsterdam UMC Locatie VUmc

NETHERLANDS

View details

Shahab Abtahi

University of Maastricht

NETHERLANDS

View details

Marieke Tabo Blom

Amsterdam University Medical Centers

NETHERLANDS

View details

Liset van Dijk

Honorary professor Pharmacy Health services research

University of Groningen

NETHERLANDS

View details

Tore B. Stage

DENMARK

View details

Helga Gardarsdottir

Associate professor

Utrecht University

NETHERLANDS

View details

Erkka Järvinen

University of Helsinki

FINLAND

View details

Jesse Swen

Full professor of clinical pharmacy, in particular translational pharmacogenetics

Leiden University Medical Center

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Patrick Souverein

Research Interests

Explore related searches

Contact this professor

Articles (10)

Dicloxacillin is an inducer of intestinal P‐glycoprotein but neither dicloxacillin nor flucloxacillin increases the risk of stroke/systemic embolism in direct oral anticoagulant users

Predictive Value of SLCO1B1 c.521T>C Polymorphism on Observed Changes in the Treatment of 1136 Statin-Users

Prescribing of low‐dose rivaroxaban in patients with atherosclerotic cardiovascular disease in the United Kingdom and the Netherlands

Incidence and individual risk prediction of post-COVID-19 cardiovascular disease in the general population: a multivariable prediction model development and validation study

Safety of off‐label dose reduction of non‐vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

Out-of-hospital cardiac arrest and differential risk of cardiac and non-cardiac QT-prolonging drugs in 37 000 cases

Opioid use is associated with increased out‐of‐hospital cardiac arrest risk among 40 000‐cases across two countries

Indications related to antidepressant prescribing in the Nivel-PCD database and the SIDIAP database

Sulfonylurea antidiabetics are associated with lower risk of out-of-hospital cardiac arrest: Real-world data from a population-based study

Impact of anticoagulant exposure misclassification on the bleeding risk of direct oral anticoagulants

Collaborators (11)

Harsha D. Devalla

Sander van Doorn

Tessel Rigter

Martina Cornel

Shahab Abtahi

Marieke Tabo Blom

Liset van Dijk

Tore B. Stage

Helga Gardarsdottir

Erkka Järvinen

Jesse Swen

Make your next move.